Published in Circ Res on May 14, 2004
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev (2009) 1.90
A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest (2010) 1.61
Mechanical properties and compositions of tissue engineered and native arteries. Ann Biomed Eng (2007) 1.51
Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice. Arterioscler Thromb Vasc Biol (2015) 1.40
Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog. Circulation (2009) 1.39
NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells. Arterioscler Thromb Vasc Biol (2015) 1.39
The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis. Nat Commun (2013) 1.38
Repression of versican expression by microRNA-143. J Biol Chem (2010) 1.33
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol (2012) 1.30
Versican degradation and vascular disease. Trends Cardiovasc Med (2006) 1.23
Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circ Res (2008) 1.15
Genetic basis of atherosclerosis: insights from mice and humans. Circ Res (2012) 1.14
Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol (2009) 1.10
Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc Natl Acad Sci U S A (2005) 1.09
Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci (2009) 1.09
Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue. PLoS One (2010) 1.08
Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation. J Histochem Cytochem (2009) 1.05
A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. Biophys J (2005) 1.02
Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardiovasc Pathol (2010) 1.01
Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta (2008) 1.00
Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2014) 0.99
Versican and the regulation of cell phenotype in disease. Biochim Biophys Acta (2014) 0.99
Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation. Arterioscler Thromb Vasc Biol (2011) 0.99
Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry. Mol Cell Proteomics (2005) 0.99
miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol (2012) 0.98
Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol (2008) 0.95
Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican. Arterioscler Thromb Vasc Biol (2008) 0.95
Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem (2012) 0.93
Involvement of heparanase in atherosclerosis and other vessel wall pathologies. Matrix Biol (2013) 0.93
Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly. Tissue Eng Part B Rev (2012) 0.92
Controlled and uncontrolled asthma display distinct alveolar tissue matrix compositions. Respir Res (2014) 0.90
Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine. Atherosclerosis (2010) 0.89
Foam Cell Formation In Vivo Converts Macrophages to a Pro-Fibrotic Phenotype. PLoS One (2015) 0.89
Cell death-associated ADAMTS4 and versican degradation in vascular tissue. J Histochem Cytochem (2009) 0.87
A MMP derived versican neo-epitope is elevated in plasma from patients with atherosclerotic heart disease. Int J Clin Exp Med (2013) 0.86
Inflammation amplification by Versican: the first mediator. Int J Mol Sci (2012) 0.85
Osmotic pressure of aqueous chondroitin sulfate solution: a molecular modeling investigation. Biophys J (2005) 0.85
Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease. Brain Behav Immun (2014) 0.85
Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule. Wien Med Wochenschr (2006) 0.85
Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM. Atherosclerosis (2006) 0.85
Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs. Tissue Eng Part A (2010) 0.84
Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer. J Cancer Res Clin Oncol (2009) 0.84
Imbalanced expression of Vcan mRNA splice form proteins alters heart morphology and cellular protein profiles. PLoS One (2014) 0.83
Increased renal versican expression is associated with progression of chronic kidney disease. PLoS One (2012) 0.82
Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice. Am J Pathol (2008) 0.81
Cancer metastasis and EGFR signaling is suppressed by amiodarone-induced versican V2. Oncotarget (2015) 0.81
Glycosaminoglycan overproduction in the aorta increases aortic calcification in murine chronic kidney disease. J Am Heart Assoc (2013) 0.81
Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study. Atherosclerosis (2015) 0.81
Versican: a novel modulator of hepatic fibrosis. Lab Invest (2016) 0.80
Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes. J Biol Chem (2015) 0.80
Plaque Tissue Components Obtained from De Novo Lesions may Predict Restenosis after Directional Coronary Atherectomy. Ann Vasc Dis (2010) 0.80
Glycosaminoglycan metabolism defects and atherosclerosis: frequent association of endothelial dysfunction in patients with Mucopolysaccharidosis. J Inherit Metab Dis (2013) 0.79
Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development. Am J Transl Res (2013) 0.79
Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart Int (2012) 0.79
Biopharmacology of enzyme conjugates: vasoprotective activity of supramolecular superoxide dismutase-chondroitin sulfate-catalase derivative. Acta Naturae (2010) 0.78
Hyperhomocysteinemia promotes vascular remodeling in vein graph in mice. Front Biosci (Landmark Ed) (2014) 0.77
Mechanisms of Hypoxic Up-Regulation of Versican Gene Expression in Macrophages. PLoS One (2015) 0.77
Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo. Matrix Biol (2015) 0.77
Vascular proteomics in metabolic and cardiovascular diseases. J Intern Med (2016) 0.76
An overview of potential molecular mechanisms involved in VSMC phenotypic modulation. Histochem Cell Biol (2015) 0.76
Provisional matrix: A role for versican and hyaluronan. Matrix Biol (2016) 0.75
Vascular biomechanical properties in mice with smooth muscle specific deletion of Ndst1. Mol Cell Biochem (2013) 0.75
Detection of coronary atherosclerotic plaques with superficial proteoglycans and foam cells using real-time intrinsic fluorescence spectroscopy. Atherosclerosis (2010) 0.75
Matrix factorization reveals aging-specific co-expression gene modules in the fat and muscle tissues in nonhuman primates. Sci Rep (2016) 0.75
Histopathological Characteristics of Post-inflamed Coronary Arteries in Kawasaki Disease-like Vasculitis of Rabbits. Acta Histochem Cytochem (2016) 0.75
Versican accumulates in vascular lesions in pulmonary arterial hypertension. Pulm Circ (2016) 0.75
Association of versican turnover with all-cause mortality in patients on haemodialysis. PLoS One (2014) 0.75
Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice. Sci Rep (2016) 0.75
Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients. Diabetologia (2015) 1.42
Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol (2002) 1.27
Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res (2005) 1.24
Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM). Sci Transl Med (2012) 1.03
Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation (2007) 1.02
The macrophage is the predominant inflammatory cell in renal allograft intimal arteritis. Transplantation (2005) 0.92
Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs. Tissue Eng Part A (2010) 0.84
Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung. J Cell Mol Med (2012) 0.83
Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Nephrology (Carlton) (2006) 0.79
Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients: additional data regarding cause of death. Diabetologia (2015) 0.75
Erratum to: Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients. Diabetologia (2015) 0.75